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Abstract
Background: Epithelial-to-mesenchymal transition (EMT) has been associated with the acquisition of metastatic
potential and the resistance of cancer cells to therapeutic treatments. MCF-7 breast cancer cells engineered to
constitutively express the zinc-finger transcriptional repressor gene Snail (MCF-7-Snail cells) have been previously
shown to display morphological and molecular changes characteristic of EMT. We report here the results of a
comprehensive systems level molecular analysis of changes in global patterns of gene expression and levels of
glutathione and reactive oxygen species (ROS) in MCF-7-Snail cells and the consequence of these changes on the
sensitivity of cells to radiation treatment and therapeutic drugs.
Methods: Snail-induced changes in global patterns of gene expression were identified by microarray profiling
using the Affymetrix platform (U133 Plus 2.0). The resulting data were processed and analyzed by a variety of
system level analytical methods. Levels of ROS and glutathione (GSH) were determined by fluorescent and
luminescence assays, and nuclear levels of NF-κB protein were determined by an ELISA based method. The
sensitivity of cells to ionizing radiation and anticancer drugs was determined using a resazurin-based cell
cytotoxicity assay.
Results: Constitutive ectopic expression of Snail in epithelial-like, luminal A-type MCF-7 cells induced significant
changes in the expression of >7600 genes including gene and miRNA regulators of EMT. Mesenchymal-like
MCF-7-Snail cells acquired molecular profiles characteristic of triple-negative, claudin-low breast cancer cells,
and displayed increased sensitivity to radiation treatment, and increased, decreased or no change in sensitivity
to a variety of anticancer drugs. Elevated ROS levels in MCF-7-Snail cells were unexpectedly not positively
correlated with NF-κB activity.
Conclusions: Ectopic expression of Snail in MCF-7 cells resulted in morphological and molecular changes
previously associated with EMT. The results underscore the complexity and cell-type dependent nature of
the EMT process and indicate that EMT is not necessarily predictive of decreased resistance to radiation and
drug-based therapies.
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Background
Breast cancer is the most common female malignancy
worldwide with an estimated 1.67 million new cases in
2012 [1]. Despite significant recent progress in the diag-
nosis and treatment of this biologically and clinically
heterogeneous disease, breast cancer remains the most
frequent cause of cancer death among women in less
developed regions of the world and the second-leading
cause of cancer death among women in developed
nations [1, 2]. As is the case with most cancers, breast
cancer-related deaths are primarily due to metastasis.
Metastatic breast cancer (MBC) is present in ~6 % of
patients at the time of initial diagnosis and eventually
develops in 20–50 % of all breast cancer patients [2].
Since MBC is currently an incurable condition with
median survival time of only 0.5–2.2 years, depending
on subtype [3], it continues to be a challenging problem
in both basic and clinical cancer research.
Epithelial-to-mesenchymal transition (EMT) is an
essential process in normal embryonic development
[4, 5] and has been associated with the acquisition of
metastatic potential [6, 7] and the resistance of breast
and other types of cancers to ionizing radiation [8]
and anticancer drugs (reviewed in [9]). One of the
genes frequently associated with EMT is the zinc-finger
transcriptional repressor Snail (SNAI1) [10]. Snail,
together with Slug (SNAI2) and Smuc (SNAI3), comprises
the Snail family of transcription factors [11]. Previous
studies indicate that both Snail and Slug may contribute
to the progression of breast and other types of cancer by
the down regulation of E-cadherin (CDH1) and other
genes associated with the epithelial phenotype and the up
regulation of genes associated with the mesenchymal
phenotype (reviewed in [10, 12]).
In this study, we were interested in characterizing, on
a molecular systems level, the role of Snail in breast
cancer EMT and the consequence of this transition on
the sensitivity of breast cancer cells to a variety of thera-
peutic treatments. Toward this end, we performed
system level analyses of differences in global patterns of
gene expression and therapeutic response profiles between
two cell lines derived from the well-studied epithelial breast
cancer cell line MCF-7 (Michigan Cancer Foundation-7)
[13]. MCF-7-Snail is a derivative of MCF-7 that has been
stably transfected with a variant (Snail-6SA) of Snail and
displays a mesenchymal-like morphology. Snail-6SA is a
more stable protein than wild-type Snail and it has been
shown to display constitutive activity and ability to
induce EMT [14, 15]. MCF-7-Control is a derivative
of MCF-7 that has been transfected with an empty
vector and displays the same epithelial morphology as
the parental MCF-7 cell line [14].
We report here that MCF-7-Snail cells display significant
changes in the expression of several master regulators of
EMT, including various zinc-finger and basic helix-loop-
helix transcription factors, as well as members of the
miR-200 family of microRNAs. While MCF-7-Control
cells display molecular profiles characteristic of the
luminal A (ER-positive, PR-positive, HER2-negative)
breast cancer subtype, MCF-7-Snail cells were found
to display molecular profiles characteristic of the aggressive
triple-negative (ER-negative, PR-negative, HER2-negative),
claudin-low breast cancer subtype. In addition, we
found that relative to the MCF-7-Control, MCF-7-
Snail cells display a higher level of cellular ROS,
lower levels of GSH and NF-κB (nuclear factor
kappa-light-chain-enhancer of activated B cells) ac-
tivity, increased sensitivity to ionizing radiation and
increased, decreased or no change in sensitivity to
several anti-cancer drugs. Our results underscore the
complexity of the EMT process in breast cancer cells
and its consequence on cancer therapies.
Methods
Cell lines
MCF-7-Snail and MCF-7-Control cells, developed as
previously described [14], were kindly provided by Dr.
Valerie Odero-Marah (Clark Atlanta University). Trans-
fected MCF-7-Snail and MCF-7-Control cells were selected
from several clones to display the highest expression of
Snail or the highest phenotypic similarity (doubling time)
to the parental MCF-7 cells, respectively. Over-expression
of Snail in MCF-7-Snail cells has been demonstrated using
the western blot analysis [16]. Cells were routinely
maintained in RPMI 1640 medium supplemented with
10 % FBS (Atlanta Biologicals, Lawrenceville, GA), 1 %
antibiotic-antimycotic solution (Mediatech-Cellgro, Manas-
sas, VA) and 400 μg/mL G418 (Geneticin, GIBCO) at 37 °C
in a humidified atmosphere with 5 % CO2 and sub-cultured
when they reach ~80 % confluence. In all experiments, cells
were no more than four passages from the originally
receivedMCF-7-Snail andMCF-7-Control cells.
Expression analysis by microarray
MCF-7-Snail and MCF-7-Control cells (three replicates
per cell line) were grown in the above-described medium
and processed for microarray analysis using the Human
Genome U133 Plus 2.0 Array (Affymetrix, Santa Clara,
CA, USA). The resulting data were acquired as CEL files
and processed with Expression Console software Build
1.2.1.20 (Affymetrix, Santa Clara, CA, USA) using the
Affymetrix default analysis setting for PLIER and MAS
5.0 algorithms with annotation file HG-U133 Plus_2, Re-
lease 34 from 10/24/2013 (www.affymetrix.com). A detailed
description of the microarray experiment and the resulting
data are available in the Gene Expression Omnibus reposi-
tory (GEO, http://www.ncbi.nlm.nih.gov/geo/) under the
accession number GSE58252.
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Differential expression analysis
Expression signals were converted to PLIER+16 and
log2-transformed. Probe sets that displayed absent detec-
tion calls (MAS5.0 algorithm) across all chips were
removed and log2 PLIER+16 values were used to identify
genes differentially expressed between MCF-7-Snail and
MCF-7-Control cells using the Significance Analysis of
Microarrays (SAM) version 4.01 [17]. Genes were
reported as differentially expressed at FDR = 2.12 % and
absolute fold change (FC) ≥1.5. Differential gene expres-
sion was interpreted in the context of EMT and resist-
ance to anticancer drugs using manually curated lists of
71 genes relevant to EMT and 53 genes relevant to
anticancer drug resistance (these genes and their
Affymetrix probe set IDs are listed in Additional file 1).
The threshold for the expression signal intensities that
allows identification of genes as highly likely “not
expressed” was calculated by the “funnel-shaped
procedure” described by Saviozzi et al. [18] and
used to support lack of expression of selected genes
(Additional file 2: Figure S1).
Pathway enrichment analysis
Probesets corresponding to differentially expressed
genes were employed for enrichment analysis using
the MetaCore suite 6.18 build 65,505 (Thomson Reuters,
New York, NY, USA). Briefly, significantly perturbed path-
ways and process networks were identified by mapping
differentially expressed genes onto manually curated Gen-
eGO canonical pathway maps and cell process network
models [19].
Interactome analysis
For each protein from the list of differentially
expressed genes between MCF-7-Snail and MCF-7-
Control cells, one step interaction neighbors from
the global human interactome were identified using
the MetaCore “interactome by protein function” tool
(MetaCore suite 6.18 build 65,505; Thomson Reu-
ters) and the local interactome was built by adding
them to the protein interaction network built from
genes differentially expressed between MCF-7-Snail
and MCF-7-Control cells. Observed connectivity of
each protein (network object) from this local interac-
tome was compared to its expected connectivity
based on the global human interactome and relative
connectivity (connectivity ratio) was calculated to
identify over-connected or under-connected network
objects. Statistical significance of differences between
observed and expected connectivities was evaluated
using the hypergeometric test and multiplicity was
controlled by the FDR procedure [20]. The list of
over-connected network objects at FDR = 0.01 was
reported.
Transcriptional network building
To elucidate complex relationships among the regulators
of EMT in our dataset, a custom transcriptional network
was built using the results of the differential expression
analysis, previously reported associations between genes
and EMT, as well as previously reported information on
transcriptional regulation and influence on expression
between selected network objects. Differentially expressed
(i) transcription factors that were previously reported as
major regulators of EMT, (ii) microRNA-200 family mem-
bers, and (iii) epithelial or mesenchymal phenotype-
associated genes coding for adherence junctions, tight
junctions and intermediate filaments were employed to
build the transcriptional network using the knowledge-
based system MapEditor (MetaCore suite 6.18 build
65,505; Thomson Reuters). Relative expression data for
network objects were color coded (red: up-regulation;
blue: down-regulation in MCF-7-Snail relative to MCF-7-
Control cells) and mapped on the transcriptional network.
Network objects (genes) were connected in the network
if their transcription regulation relationships were pre-
viously documented and included in the MetaCore
knowledge base.
Gene Set Enrichment Analysis (GSEA)
To identify gene sets significantly enriched in a given
phenotype (MCF-7-Snail or MCF-7-Control), GSEA [21]
was performed on the data processed by PLIER+16 with-
out any pre-filtering of probe sets, using categorical
phenotype labels, gene set permutation type and signal-
to-noise metrics. The following gene sets were employed
in the analysis: C2: Curated Gene Sets (4722 gene sets)
and C6: Oncogenic Signatures (189 gene sets) from the
Molecular Signatures Database (http://www.broadinsti-
tute.org/gsea/msigdb/collections.jsp).
In all enrichment analyses, the statistical significance
of enrichment was evaluated using p-values calculated
based on hypergeometric distribution and corrected for
multiplicity using the false discovery rate (FDR) proced-
ure. Unless stated otherwise, pathways, process networks
or gene sets were considered to be significantly enriched,
if their q-values were ≤ FDR threshold, for which the
expected number of false positive entities was ≤1.
MicroRNA expression analysis by qPCR
Relative expression of miRNA-429, miR-200a, miR-200b
and miR-141 in MCF-7-Snail vs MCF-7-Control cells
was determined by qPCR using specific TaqMan miRNA
assays for miRNA-429, miR-200a, miR-200b and miR-
141, and non-coding small nuclear RNA RNU6B as an
endogenous reference (Applied Biosystems/Life Tech-
nologies, Carlsbad, CA). Total cell RNA was isolated
using the mirVana miRNA Isolation Kit (Ambion, Foster
City, CA, USA) and cDNAs were prepared using the
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miRNA-specific stem-loop RT primers and TaqMan
MicroRNA Reverse Transcription Kit following the manu-
facturer’s recommendation. Thereafter, cDNA was ampli-
fied using the TaqMan Universal Master Mix II with UNG
in the CFX96 Real Time PCR Detection System (BioRad,
Hercules, CA) following the manufacturer’s recommenda-
tion. Expressions of individual miRNAs in MCF-7-Snail
relative to MCF-7-Control cells was calculated from the
threshold cycles using the REST 2009 Software (Qiagen,
Valencia, CA, USA) [22] and expressed as means, and the
95 % confidence intervals calculated by bootstrapping
technique without normality or symmetrical distribution
assumptions. P-values determined by a randomization test
represent the probability that the observed difference in
expression between MCF-7-Snail and MCF-7-Control
cells is due to chance.
Determination of radiation sensitivity
One hundred thousand cells were plated in 2.5 mL of
RPMI 1640 medium supplemented with 10 % FBS in
35 mm tissue culture dishes (Corning Incorporated,
Corning, NY, USA). After 24 h, the cultures were irradi-
ated in an RS-2000 X-ray irradiator (Rad Source Tech-
nologies, Suwanee, GA) at 160 kV and 25 mA on an
aluminum specimen shelf four at dose rate ~ 311 cGy/
min and single dose levels 2 Gy (39 s), 4 Gy (77 s) and
8 Gy (154 s). Control medium was irradiated at 4 Gy.
After the irradiation, cells were allowed to grow for 72 h
at 37 °C in a humidified atmosphere with 5 % CO2. For
quantification of viable cells, 200 μL of Tox-8 reagent
were added to each dish and incubated for 2.5 h at 37 °C
in a humidified atmosphere with 5 % CO2. Thereafter,
the specimens were transferred to a 96-well plate
(200 μL/well) and viable cells were quantified via fluor-
escence at 560 nm excitation and 590 nm emission. The
results were expressed as % of non-irradiated control.
Determination of cell cycle distribution
Cells plated in parallel with cells used in the radiation
sensitivity experiment were cultured for 24 h, harvested
by trypsinization, fixed and stained for DNA analysis by
flow cytometry as previously described [23]. Cell cycle
distribution was determined by deconvolution of DNA
content histograms, after discrimination of doublets and
other cellular aggregates by FlowJo 7.6.5 software (Tree
Star, Inc., Ashland, OR, USA) using the Dean-Jet-Fox
Model. For each cell line, the flow cytometry DNA
analysis was performed on three independent cell
cultures and the results are presented as means from
these three experiments.
Determination of intracellular level of ROS
MCF-7-Snail and MCF-7-Control cells in the RPMI-1640
medium supplemented with 10 % FBS (20,000 cells/mL)
were plated into 96-well black-walled plate (100 μL/well)
and incubated for 48 h at 37 °C in a humidified atmos-
phere with 5 % CO2. Thereafter, the medium was
removed and 10 μM solution of 2′,7′-dichlorodihydro-
fluorescein diacetate (H2DCF-DA, Molecular Probes,
Inc., Eugene, OR) in PBS was added to each well
(100 μL/well). H2DCF-DA is a general oxidative stress
indicator that can detect several types of ROS including
hydrogen peroxide, hydroxyl radicals and peroxynitrite
[24]. Cells were incubated for additional 30 min at 37 °C
in a humidified atmosphere with 5 % CO2 and the fluor-
escence of the ROS-sensitive dye was measured by a
Synergy 4 microplate reader (Biotek, Winooski, VT) with
filter set 485/20 nm (excitation), 528/20 nm (emission)
and 510 nm full-size mirror. Fluorescence intensity
corresponding to the ROS signal was normalized to the
quantity of viable cells per well as determined by TOX-8
assay and expressed as mean±SD.
Determination of cellular glutathione
MCF-7-Snail and MCF-7-Control cells in DMEM
medium (glutathione-free) supplemented with 10 % FBS
(20,000 cells/mL) were plated onto the tissue culture-
treated 96-well white-walled plate (100 μL/well) and
incubated for 48 h at 37 °C in a humidified atmosphere
with 5 % CO2.
Reduced glutathione (GSH) and total cellular glutathi-
one (GSH+GSSG) in MCF-7-Snail and MCF-7-Control
cells were quantified using the GSH-Glo Glutathione
Assay (Promega, Madison, WI, USA). In this assay, the
luciferin derivative Luc-NT is converted in the presence
of GSH and glutathione S-transferase (GST) to luciferin
that generates a luminescent signal in a coupled reaction
catalyzed by firefly luciferase. The assay was performed
following the manufacturer’s instructions for adherent
cell cultures.
Total cellular glutathione was determined after reduc-
tion of GSSG to GSH with tris(2-carboxyethyl) phosphine
(TCEP, final concentration 1 mM). The luminescence sig-
nal after subtraction of blanks (net RLU) was normalized
to the number of viable cells determined by resazurin-
based cell viability assay TOX-8 (Sigma–Aldrich, St. Louis,
MO). All experiments were performed in triplicate.
Determination of the level of nuclear NF-κB
MCF-7-Snail and MCF-7-Control cells each in three
replicated cultures were grown in full growth medium to
~80 % confluence, harvested by scraping and processed
to obtain nuclear protein extracts using the CelLytic
NuCLEAR Extraction Kit (Sigma-Aldrich) following the
manufacturer’s protocol. Protein concentration in nu-
clear extracts was determined using the Pierce 660 nm
Protein Assay (Thermo Scientific, Rockford, IL). NF-κB
(p50 subunit) was determined in nuclear protein extracts
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by an ELISA-based assay using the NF-κB (human p50)
Transcription Factor Assay Kit (Cayman Chemical
Company, Ann Arbor, MI, USA) in 96-well assay format
following the manufacturer’s protocol. After developing
plates, the stop solution was added and signals corre-
sponding to the p50 protein levels were read as A450 - A570.
Concentration of nuclear NF-κB was expressed as
A450 - A570 corrected for non-specific binding signal
and normalized to protein concentration in nuclear
extracts. The results were expressed as means±SDs.
Determination of drug sensitivity
Sensitivity of MCF-7-Snail and MCF-7-Control cells to
the cytotoxic effects of selected conventional anticancer
drugs was evaluated using the resazurin-based in vitro
toxicology assay kit TOX-8 (Sigma–Aldrich) as previ-
ously described [23]. Aliquots of cell suspensions
(100 μL/well) were plated onto 96-well black-walled
plates at 30,000 cells/mL in RPMI 1640 medium supple-
mented with 10 % FBS, 1 % antibiotic-antimycotic solu-
tion and 400 μg/mL G418. Tested compounds were
diluted from the following stock solutions: vincristine
(VCR) - 0.4 mM in DMSO; doxorubicin (DOX) – 2 mM
in DMSO; methotrexate (MTX) – 1 mM in DMSO;
gemcitabine (GEM) – 10 mM in H2O; mitomycin C
(MMC) – 10 mM in DMSO; 5-fluorouracil (5-FU) –
16.5 mM in H2O; cisplatin (CPT) – 1.7 mM in 0.9 %
NaCl/H2O. Tested compounds dissolved in growth
medium at a concentration twice the desired final
concentration were added in quadruplicates at 100 μL
volumes per well. Incubation of cells with drugs or con-
trol medium proceeded for 72 h. After that, 20 μL of the
TOX-8 reagent were added to each well and incubated
for the next 3 h. The increase of fluorescence was
measured at a wavelength of 590 nm using an excitation
wavelength of 560 nm. The emission of control wells (no
drug treatment) after the subtraction of a blank was
taken as 100 % and the results for treatments were
expressed as a percentage of the control. The experi-
ment was performed four times and GI50 values (con-
centrations of tested agents that inhibited growth of cell
cultures after 72-h incubation to 50 % of the untreated
control) were determined by non-linear regression of
log-transformed data using a normalized response-
variable slope model (GraphPad Prism 5.01; GraphPad
Software, Inc.) and expressed as mean ± SD.
Statistical analyses
Unless stated otherwise, the statistical significance of
differences between means of continuous data was eval-
uated by Welch-corrected t-test and considered signifi-
cant for two-tailed p-values <0.05. In the analysis of
microarray data, multiplicity of statistical tests was
corrected by the FDR approach and the discoveries were
considered significant if their rank and q-value would
allow not more than one false discovery. When multiple
comparisons were performed in other experiments,
p-values were adjusted by the Šidák-Holm approach
and considered significant for padj <0.05. Unless
stated otherwise, results of continuous variables were
expressed as means±SD.
Results
MCF-7-Snail cells display morphological and molecular
changes characteristic of EMT
MCF-7-Snail cells display an elongated morphology
characteristic of mesenchymal-like breast cancer cells
(Fig. 1a-b). In contrast MCF-7-Control cells, like their
parental MCF-7 cells, display the classic “cobble-stone”
morphology characteristic of breast cancer epithelial
cells (Fig. 1c-d). Consistent with these morphological
differences, MCF-7-Snail and MCF-7-Control cells are
remarkably different in their respective patterns of gene
expression (Additional file 2: Figure S2).
Among 38,226 probe sets included in the differential
expression analysis, over 12,000 probe sets corresponding
to 7602 genes were found to display statistically significant
differences in expression (4242 up-regulated; 3291 down-
regulated; 69 discordant) between MCF-7-Snail and MCF-
7-Control cells (FDR = 2.12 % and |FC| ≥1.5 (Additional
file 2: Figure S3, Additional files 3 and 4). Among the
genes significantly differentially expressed are many that
have been previously implicated in EMT, including tran-
scription factors Slug, Zeb1, Zeb2, Twist1 [25] and TCF4
[26] (Fig. 2). Among the differentially expressed genes 69
genes displayed discordant expression with some probe
sets detecting their up regulation and other probe sets
detecting down regulation (Additional file 4). The over-
expression of SNAI1 (Snail) and SNAI2 (Slug) genes in
MCF-7-Snail relative to MCF-7-Control cells was con-
firmed by qPCR (Additional file 2: Figure S4 and
Additional file 2: Method S1. We have previously reported
the up-regulation of mesenchymal markers CDH2 and
VIM and down-regulation of epithelial marker CDH1 in
MCF-7-Snail cells by RT-PCR [27].
The miR-200 family of microRNAs are significantly down-
regulated in MCF-7-Snail cells
The regulatory role of microRNAs in EMT is an area of
growing interest for both developmental and cancer
biologists [28]. Members of the miR-200 family of
microRNAs are of particular interest because they have
been previously shown to target genes that play central
roles in EMT (e.g., Zeb1, Zeb2, Slug) [29, 30]. In
addition, more recent studies have demonstrated that
miR-429 and other members of the miR-200 family are
down regulated in ovarian cancer mesenchymal-like cells
and that ectopic over-expression of these miRNAs in
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these cells is sufficient to induce mesenchymal-to-
epithelial transition (MET) [31–33]. In light of these
findings and because Snail-induced repression of miR-
200 family miRNAs has recently been implicated with
EMT in embryonic stem cells (ESC) [34], we examined
levels of miR-200 members in MCF-7-Snail cells relative
to controls.
The results of comparative qPCR expression analyses
of four miRNA-200 family members in MCF-7-Snail
and MCF-7-Control cells indicate that levels of miR-200
family microRNAs are consistently and significantly
reduced in the mesenchymal-like MCF-7-Snail cells
(Fig. 3). Since a number of EMT associated genes are
known or predicted targets of miR-200 family members
Fig. 1 Brightfield (phase contrast) micrographs of MCF-7-Snail and MCF-7-Control cells. Shown are MCF-7-Snail (a, b) and MCF-7 Control cells (c, d).
Magnification: 100× (a, c) or 200× (b, d). Scale bars: 100 μm, (a, c) and 50 μm (b, d)
Fig. 2 Relative expression of a subset of the 71 EMT-related genes in MCF-7-Snail vs MCF-7-Control cells. Results shown in log2 scale
(from microarray data). Color-coding: Yellow= epithelial phenotype-associated genes; blue=mesenchymal phenotype-associated genes
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(Fig. 4), these findings suggest that down regulation of
members of the miR-200 family of microRNAs may
contribute to the regulatory changes associated with
EMT in MCF-7-Snail cells.
Systems analysis provides evidence of a complex
regulatory interplay between EMT-associated genes and
miR-200 family miRNAs in MCF-7-Snail cells
Transcriptional network analysis of genes and miR-200
miRNAs differentially expressed between MCF-7-Snail
and MCF-7-Control cells suggests a complex regulatory
relationship among EMT-associated transcription factors,
miR-200 family members and various cytoskeletal and
junction proteins previously associated with the epithalial/
mesenchymal phenotype (Fig. 4).
Pathway Enrichment Analysis of the 7634 network
objects that were recognized by MetaCore suite among
Fig. 3 Relative expression of miRNA 200 family members in MCF-7-Snail
vs MCF-7 Control cells. Relative expression (RE) determined by qPCR. Error
bars: 95 % CI (N= 4 replicates). P-values from randomization test: miR-429
(p= 0.008), miR-200a (p= 0.016), miR-200b (0.022), miR-141 (p= 0.015)
Fig. 4 Complex regulatory interplay among transcription factors, miRNA 200 family members and E/M-phenotype related genes. Map created
from genes differentially expressed between MCF-7-Snail and MCF-7-Control cells using MapEditor (Thomson Reuters, New York, NY, USA) to
connect network objects based on previously reported associations. Legend for edges: TR transcriptional regulation, IE influence on expression,
M microRNA binding. Green edge – activation; red edge repression. Edges originating or ending at SNAI1 are depicted as thick lines. Thermometers:
red = network object up-regulated in MCF-7-Snail cells; blue= network object down-regulated in MCF-7-Snail cells; yellow= network object identified as
over-connected to the list of differentially expressed genes. For more details on legend https://portal.genego.com/legends/
MetaCoreQuickReferenceGuide.pdf
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7602 differentially expressed genes between MCF-7-
Snail and MCF-Control cells, identified 18 significantly
enriched pathways for both up- and down-regulated
genes (Table 1, FDR = 0.06089). Likewise, six significantly
enriched pathways were identified for up-regulated genes
only (Additional file 2: Table S1, FDR = 0.1677) and 69
pathways for down-regulated genes only (Additional file 2:
Table S2, FDR = 0.01514). Mapping up- and down-
regulated genes onto GeneGO Process Network Maps
identified 30 significantly enriched networks (Table 2,
FDR = 0.03104). As expected, the enriched pathways and
networks include those related to EMT (e.g., Fig. 5,
Tables 1 and 2). Additionally implicated were other related
cellular processes including the Wnt-signaling, Hedgehog
signaling, estrogen receptor-mediated signaling, NOTCH-
signaling, ERBB-signaling, the endoplasmic reticulum
stress pathway, and reactive oxygen species (ROS)-associ-
ated processes (Tables 1 and 2).
To further explore genes differentially expressed between
MCF-7-Snail and MCF-7-Control cells, we examined their
paired (binary) protein interactions with those in the Meta-
Core human protein interaction network [20]. This interac-
tome analysis identified 164 significantly over-connected,
but no significantly under-connected human interactome
proteins (Additional file 5). The list of over-connected pro-
teins includes: (i) Snail, Slug and Twist1 consistent with
their previously recognized role in EMT [25]; (ii) GSK3B,
RYK, β-catenin (CTNNB1) and TCF7L2 (TCF4) consistent
with a role in the Wnt signaling pathway in Snail-induced
EMT [10]; (iii) ESR1, PGR (PR) and androgen receptor
suggesting a role of the sex-hormone-receptor-mediated
signaling pathway; (iv) cancer-associated transcription fac-
tors p53 (TP53) and c-Myc (MYC), and (iv) the
pluripotency-associated transcription factors KLF-4, Oct3/
4, Nanog, Sox2 [35, 36].
We next focused on transcription factor sub-networks
represented among genes significantly differentially
expressed between MCF-7-Snail and MCF-7-Control
cells. This analysis identified 31 transcription factor-
centered networks (Additional file 6) confirming a likely
role of several transcription factors previously implicated in
EMT (MYC, Oct3/4, ESR1, p53, Nanog, Sox2 and TCF-4),
in addition to others (CREB1, SP1, NF-κB, and ETS1). For
example, among the 294 genes differentially expressed
between MCF-7-Snail and MCF-7-Control cells known to
be transcriptionally activated by MYC, 240 (~82 %) were
up regulated inMCF-7-Snail cells (Additional file 7). Of the
162 genes differentially expressed between MCF-7-Snail
and MCF-7-Control cells known be transcriptionally re-
pressed by MYC, 107 (~66 %) were found to be down regu-
lated in MCF-7-Snail cells (Additional file 7). These results
suggest a significant role and up-regulated activity of MYC
in Snail-induced EMT in breast cancer.
MCF-7-Snail cells display molecular profiles characteristic
of the triple-negative breast cancer subtype
Estrogen receptor 1 (ESR1), progesterone receptor (PGR)
and ERBB2 genes were found to be significantly down-
Table 1 GeneGO pathway maps significantly enriched for both up- and down-regulated genes in MCF-7-Snail vs MCF-7-Control cells
(FDR = 0.06089); P/T – differentially expressed genes mapped to a given map/total number of genes in a map
# Pathway map p-value FDR P/T
1 Chemotaxis_C5a-induced chemotaxis 6.298E-05 3.136E-02 21/27
2 ENaC regulation in normal and CF airways 7.539E-05 3.136E-02 26/36
3 Development_TGF-beta-dependent induction of EMT via SMADs 1.394E-04 3.865E-02 25/35
4 Development_Thromboxane A2 signaling pathway 2.847E-04 5.199E-02 25/36
5 Muscle contraction_Relaxin signaling pathway 3.125E-04 5.199E-02 26/38
6 Ca(2+)-dependent NF-AT signaling in cardiac hypertrophy 5.485E-04 5.627E-02 25/37
7 Main growth factor signaling cascades in multiple myeloma cells 5.485E-04 5.627E-02 25/37
8 Cytoskeleton remodeling_RalA regulation pathway 5.733E-04 5.627E-02 19/26
9 Regulation of CFTR activity (normal and CF) 6.448E-04 5.627E-02 28/43
10 Signal transduction_Calcium signaling 8.247E-04 5.627E-02 22/32
11 Apoptosis and survival_HTR1A signaling 1.003E-03 5.627E-02 25/38
12 Development_A1 receptor signaling 1.003E-03 5.627E-02 25/38
13 Transcription_CREB pathway 1.045E-03 5.627E-02 26/40
14 Transport_Clathrin-coated vesicle cycle 1.054E-03 5.627E-02 40/68
15 PTMs in IL-17-induced CIKS-independent signaling pathways 1.079E-03 5.627E-02 27/42
16 Signal transduction_Activation of PKC via G-Protein coupled receptor 1.107E-03 5.627E-02 28/44
17 Apoptosis and survival_Endoplasmic reticulum stress response pathway 1.150E-03 5.627E-02 31/50
18 Development_Hedgehog and PTH signaling pathways in bone and cartilage development 1.345E-03 6.089E-02 20/29
Mezencev et al. BMC Cancer  (2016) 16:236 Page 8 of 21
regulated in MCF-7-Snail relative to MCF-Control cells
(Fig. 6a). In addition, the intensities of ESR1 and PGR
transcripts were below computed threshold levels, indicat-
ing that these genes are not significantly expressed in
MCF-7-Snail cells (Additional file 2: Figure S1B).
Further evidence of the involvement of ESR1 in the
molecular changes underlying the phenotypic differ-
ences between MCF-7-Snail and MCF-7-Control cells,
is the observation that ESR1 is significantly over-
connected with genes differentially expressed between
the two cell lines (Additional file 5). In addition, of the
262 genes differentially expressed between MCF-7-
Snail and MCF-7-Control cells known to be transcrip-
tionally activated by ESR1, 172 (~66 %) were found to
be down regulated in MCF-7-Snail cells (Additional
file 8). Collectively, these findings consistently indicate
that ESR1-mediated signaling is significantly reduced
in MCF-7-Snail relative to MCF-Control cells and we
have confirmed the down-regulation of ESR1 in MCF-
7-Snail cells by qPCR (Additional file 2: Figure S5a
and Additional file 2: Method S2).
Although the expression intensity of the ERBB2 gene that
encodes HER-2/neu protein appears to exceed the calcu-
lated expression threshold (Additional file 2: Figure S1B),
we conclude that the ERBB2 gene is not significantly
expressed in MCF-7-Snail cells for the following two
reasons: (i) the probe set that detected ERBB2 expression in
our dataset (216836_s_at) is not specific and may also
detect other transcripts, and (ii) differential expression
analysis identified the ERBB2 gene as down regulated upon
Table 2 GeneGO Process Networks significantly enriched for both up- and down-regulated genes in MCF-7-Snail vs MCF-7-Control
cells (FDR = 0.03104). P/T – differentially expressed genes mapped to a given map/total number of genes in a map
# Network p-value FDR P/T
1 Signal transduction_WNT signaling 1.774E-07 2.622E-05 100/170
2 Cell adhesion_Cell junctions 3.278E-07 2.622E-05 89/149
3 Cytoskeleton_Regulation of cytoskeleton rearrangement 5.064E-07 2.701E-05 104/181
4 Cell adhesion_Cadherins 1.194E-06 4.777E-05 100/175
5 Cytoskeleton_Actin filaments 3.552E-06 1.137E-04 99/176
6 Development_Hedgehog signaling 1.016E-05 2.598E-04 129/244
7 Reproduction_FSH-beta signaling pathway 1.136E-05 2.598E-04 86/152
8 Development_Neurogenesis_Axonal guidance 4.544E-05 9.088E-04 115/219
9 Signal transduction_Androgen receptor nuclear signaling 5.687E-05 9.838E-04 70/123
10 Development_Regulation of angiogenesis 6.148E-05 9.838E-04 109/207
11 Cell adhesion_Attractive and repulsive receptors 1.134E-04 1.649E-03 91/170
12 Development_Neurogenesis_Synaptogenesis 6.650E-04 7.983E-03 92/179
13 Cell cycle_G1-S Growth factor regulation 6.820E-04 7.983E-03 96/188
14 Development_Ossification and bone remodeling 7.539E-04 7.983E-03 80/153
15 Signal transduction_ESR1-nuclear pathway 8.718E-04 7.983E-03 104/207
16 Development_EMT_Regulation of epithelial-to-mesenchymal transition 8.718E-04 7.983E-03 104/207
17 Signal Transduction_Cholecystokinin signaling 8.781E-04 7.983E-03 52/93
18 Signal transduction_ERBB-family signaling 8.981E-04 7.983E-03 40/68
19 Muscle contraction_Relaxin signaling 2.135E-03 1.798E-02 37/64
20 Apoptosis_Endoplasmic reticulum stress pathway 2.366E-03 1.819E-02 44/79
21 Development_Neurogenesis in general 2.387E-03 1.819E-02 93/187
22 Neurophysiological process_Circadian rhythm 2.520E-03 1.833E-02 30/50
23 Cardiac development_FGF_ErbB signaling 2.858E-03 1.988E-02 64/123
24 Cardiac development_Wnt_beta-catenin, Notch, VEGF, IP3 and integrin signaling 3.396E-03 2.181E-02 70/137
25 Signal transduction_ESR1-membrane pathway 3.425E-03 2.181E-02 43/78
26 Cardiac development_Role of NADPH oxidase and ROS 3.669E-03 2.181E-02 64/124
27 Reproduction_Gonadotropin regulation 3.680E-03 2.181E-02 81/162
28 Signal transduction_NOTCH signaling 4.606E-03 2.629E-02 109/227
29 Signal transduction_Androgen receptor signaling cross-talk 4.766E-03 2.629E-02 35/62
30 Reproduction_Male sex differentiation 5.820E-03 3.104E-02 111/233
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ectopic expression of Snail in MCF-7 cells, which are
known to be HER-2/neu negative [37]. This conclusion is
further supported by the quantification of total HER-2/neu
protein in MCF-7-Snail and MCF-7-Control cells using the
ELISA (Additional file 2: Figure S6 and Additional file 2:
Method S3).
Taken together our results indicate that while MCF-7-
Control cells display molecular profiles characteristic of
the luminal A subtype of breast cancer (ER-positive, PR-
positive and HER-2/neu-negative) [37, 38], MCF-7-Snail
have acquired profiles characteristic of the triple-negative
(ER-negative, PR-negative, HER-2/neu-negative), breast
cancer subtype.
Gene Set Enrichment Analysis (GSEA) further supports
this conclusion in that the enrichment of gene sets previ-
ously associated with the ductal-invasive, non-luminal,
Fig. 5 GeneGO pathway map “Development_TGF-beta-dependent induction of EMT via SMADs” is significantly enriched for genes differentially
expressed between MCF-7-Snail and MCF-7-Control cells. Thermometers: red = object up-regulated in MCF-7-Snail cells; blue = object down-regulated in
MCF-7-Snail cells; yellow= network object identified as over-connected to the list of differentially expressed genes. For more details on legend
see https://portal.genego.com/legends/MetaCoreQuickReferenceGuide.pdf
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mesenchymal and/or metaplastic phenotype (e.g., activa-
tion of KRAS, LEF1, EGFR and suppression of PTEN
functions) are also significantly enriched in MCF-7-Snail
cells. Conversely, GSEA of MCF-7-Control cells demon-
strated enrichment of gene sets previously associated with
the estrogen receptor positive, luminal type, and epithelial
differentiated phenotype (Additional file 9).
Triple-negative breast cancers have been sub-classified
into specific molecular subtypes that include basal-like
breast cancers (CK5/6-positive and/or EGFR-positive)
[39] and claudin-low breast cancers exhibiting low
expression of the CDH1 and claudin 3, 4 and 7 genes
[40]. Cytokeratins 5 and 6 were not found among genes
differentially expressed between MCF-7-Snail and MCF-
7-Control cells. Consistent with the previously reported
absence of the expression of CK5/6 in MCF-7 cells [41],
our result suggests that these genes are not significantly
expressed in either MCF-7-Snail or MCF-7-Control cells.
Although the EGFR gene appears to be expressed
over the calculated threshold, and up-regulated in
MCF-7-Snail cells (Additional file 2: Figure S5b, Additional
files 3 and 4), its signal intensity is low (Additional
file 2: Figure S1B). Moreover, the ITGB4 gene previously
associated with the basal-like subtype [42] is down regu-
lated in MCF-7-Snail cells (Additional files 3 and 4).
Overall, our gene expression results do not support
the basal-like phenotype for MCF-7-Snail cells. In con-
trast, genes whose down regulation is known to be asso-
ciated with the claudin-low subtype (CLDN3, CLDN4,
CLDN7, CDH1, and ITGB4) [42] are all significantly
down regulated in MCF-7-Snail cells (Fig. 6b, Additional
file 2: Figure S1B, Additional file 3 and Additional file 4).
Collectively, our findings indicate that ectopic expression
of Snail has induced the transformation of MCF-7 cells
from the luminal A-like cells to the claudin-low triple-
negative breast cancer subtype.
Levels of reactive oxygen species (ROS) are significantly
elevated in MCF-7-Snail cells
Reactive oxygen species (ROS) are known to induce a
variety of cellular responses contributing to the develop-
ment and progression of breast and other types of
cancer [43]. Since our systems analyses indicated that
ROS-associated cellular process networks are enriched
by genes differentially expressed between MCF-7-Snail
and MCF-7-Control cells (Table 2), we explored the
possibility that the ectopic expression of Snail in MCF-7
cells might be associated with changes in levels of ROS
contributing to the process of EMT and other Snail-
mediated phenotypic changes in MCF-7-Snail cells.
The results, presented in Fig. 7, are consistent with
this hypothesis and demonstrate significantly higher
levels of ROS in mesenchymal-likeMCF-7-Snail cells rela-
tive to the MCF-7-Controls. These results are also consist-
ent with recently reported findings in mesenchymal-like
prostate cancer cells [44].
Elevated levels of ROS in MCF-7-Snail cells are associated
with decreased levels of cellular glutathione and NF-κB
activity
Increased intracellular concentrations of ROS in cancer
cells have been previously associated with decreased
levels of antioxidant enzymes and/or glutathione [45].
We compared intracellular levels of glutathione in MCF-7-
Snail and MCF-7-Control cells using a luminescence-based
assay. The results presented in Fig. 8a demonstrate lower
levels of both reduced (GSH) and total (GSH+GSSG)
glutathione levels in MCF-7-Snail cells relative to
MCF-7-Controls.
ROS have been shown to induce EMT in mouse mam-
mary epithelial cells via NF-κB-mediated activation of
Snail [46]. In addition, NF-κB was reported to play an
essential role in the induction and maintenance of EMT
in breast cancer [47]. Given the previously observed
associations between the ROS and NF-κB activity in
breast and other cancer types [48], we compared the
status of NF-κB activity in MCF-7-Snail and MCF-7-
Fig. 6 Expression of molecular markers for classification of breast
cancer subtypes and for sub-typing of triple-negative breast cancers.
Shown are log2E - logarithm of PLIER+16-processed expression signals
of molecular markers for breast cancer subtypes (a) and for sub-typing
of triple-negative breast cancers (b); ns difference between MCF-7-Snail
and MCF-7-Control cells was not significant (all other markers
are significantly differentially expressed between MCF-7-Snail
and MCF-7-Control cells at FDR = 2.12 % and absolute fold
change (FC) ≥1.5)
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Control cells. Our microarray data indicate down regula-
tion of the NF-κB1 gene in MCF-7-Snail cells (Additional
files 3 and 4). In addition, we found that the NF-κB tran-
scription network is enriched by genes differentially
expressed between MCF-7-Snail and MCF-7-Control cells
(Additional file 6). NF-κB transcript levels do not necessarily
correlate with NF-κB activity since the protein is activated
by proteasome degradation of IκB, and the subsequent
translocation of NF-κB dimers from the cytoplasm to the
nucleus [49]. Thus, measurement of NF-κB protein levels in
cell nuclei is necessary for biologically accurate estimates of
NF-κB activity. We determined the level of NF-κB (p50/
p65- the most common member of NF-κB/Rel family) by
its quantification in nuclear protein extracts using an
ELISA-based method. The results, presented in Fig. 8b,
demonstrate a significant decrease in nuclear protein levels
of NF-κB in MCF-7-Snail cells relative to controls indicat-
ing decreased nuclear translocation and activation.
The consequence of ectopic expression of Snail on drug
sensitivity is variable
Since EMT has been reported by several groups to
enhance the resistance of cancer cells to anticancer
drugs (reviewed in [9]), we evaluated the relative sensitiv-
ity of MCF-7-Snail and MCF-7-Control cells to a variety
of cancer drugs previously and/or currently employed in
breast cancer treatment (vincristine, doxorubicin [50],
mitomycin C, methotrexate [51], gemcitabine, cisplatin
[52] and 5-fluorouracil [53]). The sensitivity assay was de-
signed to compare numbers of viable cells in drug-treated
cell cultures relative to untreated controls independent of
the specific mechanisms of cell cytotoxicity. GI50 values
for each drug and cell type (Fig. 9) were determined from
dose response curves (Additional file 2: Figure S7).
The results indicate that mesenchymal-like MCF-7-
Snail cells are significantly more sensitive to doxoru-
bicin, methotrexate, cisplatin, and 5-fluorouracil rela-
tive to epithelial-like MCF-7-Control cells. Conversely,
MCF-7-Snail cells display significantly reduced sensi-
tivity to gemcitabine and mitomycin C. While the
difference in GI50 values between the two cell types is
statistically significant for MMC, the fold change (~1.6 ×)
is relatively low and, thus, of questionable biological
significance. MCF-7-Snail and MCF-7-Control cells
did not display significant differences in sensitivity to
vincristine.
Fig. 7 The level of ROS detected by H2DCF-DA staining in MCF-7-Snail vs MCF-7-Control cells. Levels of ROS detected by fluorimetry
(a) and representative epifluorescence microscopy images overlaid on brightfield images (b: MCF-7-Snail, c: MCF-7-Control cells). NFU normalized
fluorescence units, Error bars: SD; p-value = 0.0471 (two-tailed t-test); scale bar: 100 μm (*: p <0.05)
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Differences in sensitivity of MCF-7-Snail and MCF-7-
Control cells to some anticancer drugs tested in this
work can be interpreted in the context of changes in the
expression of genes known to contribute to resistance
against specific anticancer drugs (Fig. 10). For example,
increased sensitivity of MCF-7-Snail cells to cisplatin
can be attributed to the combined effect of (i) down
regulation of cisplatin-sequestering metallothioneins
MT1E, MT1F and MT1G [54], (ii) down regulation of
the ABCC3 transporter [55], down regulation of the
nucleotide excision repair enzyme ERCC1 [56], as well
as (iii) down regulation of the anti-apoptotic protein
XIAP [57], and (iv) decreased concentration of GSH
(Fig. 8a). In fact, the lower concentration of GSH in
MCF-7-Snail cells likely suppressed the effect of up
regulation of GSTP1 in MCF-7-Snail cells that would
otherwise contribute to the resistance against cisplatin
[58]. Likewise, increased sensitivity of MCF-7-Snail cells
to doxorubicin could be attributed to the down regula-
tion of HSPB1 [59] and metallothioneins [60], while
increased sensitivity to 5-FU can be attributed to the
down regulation of DPYD in MCF-7-Snail cells [61]. On
the other hand, lower sensitivity of MCF-7-Snail cells to
gemcitabine can be attributed to the up regulation of its
target, RRM1 [62]. Overall, these results indicate that
EMT is not always associated with increased resistance
to anticancer drugs.
MCF 7-Snail cells display increased radiosensitivity relative
to MCF-7-Controls
Radiotherapy is an important treatment modality for
breast cancer [63]. The efficacy of radiotherapy, however,
can be decreased by intrinsic or acquired resistance [64]
possibly associated with EMT [8, 65]. To explore this
relationship in our experimental system, we exposed
MCF-7-Snail and MCF-7-Control cells to a single dose
of X-ray radiation at 2–8 Gy and cells were allowed to
replicate for 72 h at which point the number of metabol-
ically active viable cells was determined. The results
demonstrate a significantly lower proportion of viable
MCF-7-Snail cells at 72-hours post-irradiation (Fig. 11)
indicating higher radiation sensitivity of the mesenchymal-
like MCF-7-Snail cells relative to epithelial-like MCF-7-
Control cells. Consistent with the response to radiation
Fig. 8 Levels of GSH, GSH+GSSG and nuclear NF-κB. a Levels of free (GSH) and total (GSH+GSSG) glutathione in MCF-7-Snail and MCF-7-Control
cells determined by luminescent assay; NLU normalized luminescence units; p-values (multiple t-test with Holm-Šidák correction): GSH = 9.98 × 10−5;
GSH+GSSG = 8.46 × 10−8. b Levels of nuclear NF-κB in MCF-7-Snail and MCF-7-Control cells expressed as determined by ELISA in nuclear protein lysates;
NA normalized absorbance; Error bars: SD; p = 0.0071 (Welch’s corrected t-test; **: p <0.01; ***: p <0.001)
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treatment, we also observed prominent multinucleated cells
in cultures of irradiated MCF-7-Snail cells (Fig. 11) indica-
tive of radiation-induced deregulation of mitosis and defi-
cient separation of nuclei during cytokinesis [66, 67].
Since radiosensitivity has previously been shown to be
dependent on the phase of the cell cycle [68], we exam-
ined the distribution of MCF7-Snail and MCF7-Control
cells in specific phases of the cell cycle before irradi-
ation. Cultures of MCF-7-Snail and MCF-7-Control cells
plated at densities identical to those used in the radi-
ation sensitivity experiments displayed a significantly
higher proportion of MCF-7-Snail cells in the G2/M
phase relative to MCF-7-Control cells (Holm-Šidák
corrected t-test p = 0.0059; CI95 = 2.483–14.29 %). Dif-
ferences in the proportion of the two cell types in G0/
G1 and S phases of the cell cycle were not significant
(Fig. 12 and Additional file 2: Figure S8). Since cells are
known to display their greatest sensitivity to irradiation
during mitosis and G2 phases of the cell cycle [69], the
higher proportion of MCF-7-Snail cells in the G2/M
phase of the cell cycle may contribute to their higher
radiosensitivity relative to MCF-7-Control cells.
However, different slopes of semi-log radiosensitivity
plots at a medium-high dose range (Additional file 2:
Figure S9) suggest that the observed difference in the
radiosensitivity between MCF-7-Snail and MCF-7-Control
cells cannot be attributed only to the cell cycle differences.
In an initial effort to identify molecular differences poten-
tially responsible for the observed differences in radiation
sensitivity of these two cell types, we focused on genes
previously associated with radiation resistance in breast
and other cancers and found that many of them were
significantly down regulated in MCF-7-Snail cells
(Additional file 4), e.g. IGF1R (insulin-like growth
factor one receptor) [70], REG4 (Regenerating islet-
derived protein four) [71], RALBP1 (RalA-binding
protein one) [72] and ERCC1 (excision repair cross-
complementation group one) [73]) suggesting their
potential involvement in the increased sensitivity of
MCF-7-Snail cells to radiation treatment.
Discussion
An abundance of prior evience indicates that breast
cancer progression and the development of MBC is
intimately associated with EMT [74–76]. In addition,
EMT has also been associated with the resistance of
breast and other cancers to a variety of anticancer drugs
[9] and ionizing radiation [8, 65]. While dysregulation of
the transcription factor Snail has been previously associ-
ated with EMT in breast and other cancers [10, 12], its
Fig. 9 Drug sensitivity for MCF-7-Snail and MCF-7-Control cells determined by Tox-8 assay and expressed as GI50 values. a vincristine (VCR), doxorubicin
(DOX), methotrexate (MTX), gemcitabine (GEM); b mitomycin C (MMC), 5-fluorouracil (5FU), cisplatin (CPT). Error bars: SD; N = 4 replicates.
Statistical significance of differences between mean GI50 values determined by t-test corrected by Holm-Šidák method (**: p <0.01)
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effect on system-wide molecular changes and conse-
quent changes in response to radiation and drug therap-
ies is incompletely understood. In an effort to better
understand the role of Snail in breast cancer develop-
ment, we examined an isogenic pair of breast cancer cell
lines MCF-7-Snail and MCF-7-Control. MCF-7-Snail cell
line has been previously engineered to ectopically ex-
press Snail [14]. Detailed anayses of MCF-7-Snail cells
provides a unique opportunity to evaluate biologically
and clinically significant consequences of Snail-induced
EMT in breast cancer.
Previous studies have demonstrated that MCF-7-Snail
cells display reduced expression of the epithelial marker
E-cadherin (CDH1), increased expression of the mesen-
chymal markers VIM and FN1 and enhanced migratory
capabilities relative to controls [14]. Consistent with
these earlier findings, our microarray analyses of MCF-
7-Snail cells demonstrate concerted changes in the
expression of a number of genes and pathways previ-
ously implicated in EMT [25]. Among the genes signifi-
cantly up regulated/activated in response to ectopic
Snail expression are several key transcription factors
known to be critical to EMT development (reviewed in
[77]). For example, the initial stages of EMT are believed
to require Snail-induced repression of E-cadherin, while
subsequent maintenance may require cooperation of
other key transcription factors, including Slug, E47,
Zeb2 and Twist [77]. Consistent with these expectations,
we observed significant down regulation of E-cadherin
and up regulation of Slug, E47, Zeb2, and Twist 1 in
MCF-7-Snail relative to MCF-7-Control cells.
Snail and Slug are believed to work cooperatively in
EMT [77–79]. Our results suggest that the mechanism
for Snail-mediated up regulation of Slug is through the
down regulation of estrogen receptor 1 (ESR1). Snail is a
known transcriptional repressor of ESR1 [80] that, in
turn, is a documented transcriptional repressor of Slug
[81]. Consistent with this interactive model, we observed
a significant up regulation of Slug and concurrent down
regulation of ESR1 in MCF-7-Snail cells relative to
controls. Interestingly, this down regulation of ESR1 was
found be correlated with other molecular changes indi-
cative of Snail-induced transformation of MCF-7 cells
from the luminal A to the clinically more aggressive
triple-negative, claudin-low sub-type. This finding is
consistent with the potential of Snail-targeted therapy
for the treatment of metastatic breast cancer [82].
Interactions between Snail and Slug may also contrib-
ute to our observed down regulation in the expression
of the miR-200 family of microRNAs in MCF-7-Snail
cells. In agreement with prior studies implicating mem-
bers of the miR-200 family of microRNAs with EMT/
Fig. 10 Relative expression of a subset of 53 drug resistance-related genes that displayed significantly different expression in MCF-7-Snail relative
to MCF-7-Control cells. Relative expression from microarray data is presented in log2 scale
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MET (mesenchymal-to-epithelial transition) [28, 32, 33],
we observed a significant down regulation of members
of the miR-200 family in MCF-7-Snail cells. Our gene
expression analyses suggest several possible mecha-
nisms by which ectopic expression of Snail in MCF-7
cells may be contributing to repression of miR-200
family of miRNAs.
Although Snail has been previously implicated as
an activator of Zeb1 [83] and Zeb2 [84], both of
which are well-established transcriptional repressors
of miR-200 family members [85], Snail-activation of
Zeb1/2 is believed not to be direct [83, 86]. In con-
trast, Slug is known to be a direct transcriptional
activator of Zeb1 [86] and can itself directly repress
transcription of miR-200 family members [87]. Thus,
Snail-induced activation of Slug in MCF-7-Snail cells
may contribute to the down regulation of miR-200
family microRNAs.
Our results also demonstrate a significant down regu-
lation of the transcription factor Krüppel-like factor 5
(KLF5) in MCF-7-Snail cells (Additional files 3 and 4).
KLF5 is a known transcriptional activator of miR-200
family members, as well as several other microRNAs
previously implicated in EMT (e.g., miR-205 and Let-7a/
7b/7c/7d/7e/7g) [88]. It has been previously suggested
that KLF5-Smads-p300 complexes activate while ZEB1/
2-Smads-p300 complexes repress the transcription of
miR-200, and that KLF5 and ZEB1/2 may physically
interact or compete to execute opposing functions in
miR-200 regulation [88].
Fig. 11 Radiation sensitivity for MCF-7-Snail and MCF-7-Control cells. I Radiation sensitivity determined from the number of viable cells 72 h
post-irradiation by specified doses of X-ray. Viable cells [%] corresponds to the number of viable cells determined by Tox-8 assay in treatment
relative to non-irradiated control cultures (N = 2 replicates; *: p <0.05; **: p <0.01); error bars = SD. II Micrographs of MCF-7-Snail (a, b) and MCF-7-Control
cells (c, d) 72 h post-irradiation with 0 Gy (a, c) or 4 Gy (b, d). Scale bar: 100 μm. SN =MCF-7-Snail cells; CT =MCF-7-Control cells
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A third possible mechanism of miR-200 family down
regulation suggested by our results involves the nuclear
receptor PELP1 and the histone deacetylase HDAC2.
Both of these genes were found to be significantly up
regulated in MCF-7-Snail cells (Additional files 3 and 4).
It has recently been shown that PELP1, in cooperation
with histone deacetylase HDAC2, can transcriptionally
repress mir-200 family microRNAs [89]. Interestingly,
we also found that MYC, a known transcriptional acti-
vator of PELP1 [90], is functionally activated in MCF-
7-Snail cells. None of the above possible modes of
miR-200 family repression are mutually exclusive and
suggest a redundant and highly interactive nature of
Snail regulatory controls.
Previous studies have implicated Snail-induced activa-
tion of TGF-β with EMT in breast cancer cells [91, 92].
While our pathway enrichment analysis identified “TGF-
beta-dependent induction of EMT via SMADs” as a
significantly enriched pathway (Table 1), this does not
necessarily imply TGF-β activation. In fact, our gene
expression analysis indicates down-regulation of TGFB1-
3, SMAD2 and SMAD3 genes in MCF-7-Snail cells
(Additional files 3 and 4) which argues against activation
of TGF-β mediated signaling via receptor-regulated
Smads [93]. In addition, we failed to observe up regula-
tion of known downstreatm targets of TGF-β (e.g.,
CTGF, ligand TGFB2 and receptor TGFBR2) in MCF-7-
Snail cells, again suggesting the absence of TGF-β-sig-
naling. Consistent with these findings, previous studies of
claudin-low breast cancer subtypes indicate that
Snail-induced EMT need not be dependent on TGF-
β-mediated autocrine signaling [92].
Several previous studies have noted an interactive
relationship between changes in the expression of key
regulatory genes and intracellular levels of ROS in EMT
[44, 46, 94]. This regulatory relationship coupled with
their association with oxidative damage and chronic
inflammation has identified ROS as a major contributing
factor in the progression of breast and other cancers [43,
94]. Our finding that ROS levels are significantly elevated
in MCF-7-Snail cells is consistent with these and other
results indicating that elevated levels of ROS contribute to
EMTand the maintenance of the mesenchymal phenotype
in metastatic cancer cells.
Several studies have previously correlated increasing
levels of ROS with activation of the transcription factor
NF-κB, possibly as part of the stress response pathway
[48]. For example, ROS were shown to activate NF-κB
that subsequently induced the expression of Snail in
MMP3-mediated EMT of mammary epithelial cells [46].
In contrast to expectations, we observed a significant
decrease in the expression of NF-κB1 in MCF-7-Snail
cells relative to controls. We also observed a decrease in
nuclear protein levels of NF-κB in MCF-7-Snail cells
indicating reduced NF-κB activation in these cells.
Collectively, our results indicate that Snail-induced
increases in intracellular levels of ROS are not coupled
with NF-κB activation in MCF-7-Snail cells. The reduced
activation of NF-κB in MCF-7-Snail cells may be associ-
ated with glutathione depletion, consistent with a previ-
ously report that demonstrated IκB kinase-dependent and
independent down-regulation of NF-κB activity upon
glutathione depletion [95].
In addition to a systems analysis of the molecular
consequences of Snail-induced EMT in MCF-7 cells, we
were also interested in documenting the effect of these
molecular changes on drug and radiation sensitivity. A
number of prior studies have suggested that EMT is
associated with increased resistance of cancer cells to
anticancer drugs (reviewed in [9]). However, our findings
suggest that this generalization may not be universally
correct. While we found that MCF-7-Snail cells are
significantly more resistant to gemcitabine and mitomy-
cin C (MMC), they were significantly more sensitive to
doxorubicin, methotrexate, cisplatin, and 5-fluorouracil.
Similar inconsistencies between EMT and drug sensi-
tivities have been previously reported [96–98]. For ex-
ample, in a survey of the sensitivity of 54 adherent human
cancer cell lines from the NCI-60 cell panel, statistically
significant positive correlations between expression levels
of the epithelial biomarker E-cadherin and drug sensitivity
was found for only ten out of 118 drugs [96]. In another
study, non-small cell lung cancer (NSCLC) cells desig-
nated as mesenchymal-like based on their molecular
profile, were found to be more resistant than epithelial-
like NSCLC cells to erlotinib and the PI3K/AKT/mTOR
inhibitors GDC0941 and 8-aminoadenosine, but more
sensitive to pemetrexed, paclitaxel and docetaxel [97].
Similarly, two mesenchymal-like pancreatic cancer cell
lines were found to display greater sensitivity to paclitaxel
than epithelial-like pancreatic cancer cell lines [98].
Fig. 12 Cell cycle distribution of MCF-7-Snail and MCF-7-Control
cells at the time of X-ray irradiation. (means ± SEM; N = 3
replicates; **: p <0.01)
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Collectively, these findings indicate that epithelial-
mesenchymal cellular phenotypes, per se, are not
reliable predictors of relative drug sensitivity. While
such inconsistencies may simply be attributable to
other differences between cell lines that are not
consistently associated with epithelial or mesenchy-
mal phenotype, it may also be a reflection of a
continuum of potential EMT-mediated effects on
cellular phenotypes [99].
Another reflection of the inconsistency of EMT-
mediated effects on cellular phenotypes is our finding
that mesenchymal-like MCF-7-Snail cells are more sen-
sitive to radiation treatment than their parental
epithelial-like cells. In contrast to our results, a number
of previous studies have associated EMT and the mes-
enchymal cell phenotype with increased radioresis-
tance [8, 65]. For example, epithelial ovarian cancer
cells, in which the ectopic expression of Snail or Slug
resulted in the acquisition of stem cell-like properties,
were found to be associated with radioresistance [65].
Likewise, mesenchymal-like breast cancer cells that
displayed higher resistance to radiation than their par-
ental epithelial-like cells, were also found to exhibit a
stem cell-like phenotype including a CD44+/CD24-/low
molecular signature [100]. One possible explanation
of the apparent discrepancy between our results and
the accumulated evidence that mesenchymal-like can-
cer cells are generally associated with radiation resist-
ance (reviewed in [101]) is that it is the stem cell-like
properties of these cells and not EMT per se that is
responsible for their radiation resistance. While stem
cells typically display a mesenchymal-like phenotype,
not all EMT-induced mesenchymal-like cells may
display features characteristic of stem cells. For ex-
ample, it has been previously shown that cancer stem
cells typically contain lower levels of ROS than their
more differentiated progeny and that this difference is
critical for the maintenance of stem cell phenotype
[102]. In contrast, we found that MCF-7-Snail cells
contain higher levels of ROS than MCF-7-Control
cells. In addition, MCF-7-Snail cells display down
regulation of Sox2 and Nanog (Additional files 3 and
4) that have been previously shown to contribute to
the maintenance of pluripotency and the self-renewal
properties of human embryonic stem cells [103]. In
addition, we found that other stem cell biomarkers
are also down regulated or unchanged in expression
in MCF-7-Snail cells relative to controls (e.g., UTF1
[104], FBXO15 [105], ALDH1A3 [106], CD44, CD133
and ITGB1 [107]). Furthermore, previous studies have
also reported down-regulation of several genes associated
with stem cell phenotype early (ABCG2 [108], CD44,
ALDH1A3) or late (SOX9 [109]) after induction of Snail
expression in immortalized human mammary epithelial
MCF10A cells [15]. Collectively, these findings indicate
that MCF-7-Snail cells are not stem cell-like cells and that
EMT per se does not necessarily lead to the acquisition of
resistance to radiation and anticancer drugs.
Conclusions
Constitutive ectopic expression of Snail in the epithelial-
like, luminal A-type, breast cancer cell line MCF-7 results
in significant changes in the expression >7600 genes
including master gene and miRNA regulators of EMT.
Ectopic expression of Snail induced MCF-7 cells to
undergo EMT and to acquire features characteristic of
triple-negative, claudin-low breast cancer cells but not
of breast cancer stem-like cells. Snail-induced EMT
of MCF-7 cells resulted in increased sensitivity to radi-
ation treatment but increased, decreased or no change in
sensitivity to a variety of anticancer drugs indicating that
EMT is not necessarily predictive of decreased responsive-
ness to therapeutic treatments. These results underscore
the complexity and cell-context dependent nature of
EMT-mediated changes in breast cancer cells.
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